Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
06/2011
06/01/2011CN102083793A Protease inhibitors
06/01/2011CN102083792A Compounds comprising a cyclobutoxy group
06/01/2011CN102079729A Compounds with antiparasitic activity and medicaments containing them
06/01/2011CN102079707A Mesitylene group aromatic ketone compound, preparation method thereof and photoinitiator
06/01/2011CN102079700A Method for synthesizing novel tetracyclic diterpene compound from stevioside
06/01/2011CN101704801B Cinepazide oxynitride, and preparation method and applications thereof
06/01/2011CN101248053B N-oxides as prodrugs of piperazine and piperidine derivatives
05/2011
05/31/2011US7951972 Human adam-10 inhibitors
05/31/2011US7951961 Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof
05/31/2011US7951943 Method for preparing and purifying 3-hydroxyamidinophenylalanine compounds
05/31/2011US7951939 Methods and intermediates for the synthesis of porphyrins
05/31/2011US7951804 Inhibitors of coagulation factors; Thrombosis, tumors, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis; example, 1-(4-chlorophenyl)-3-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-phenylethyl]urea
05/31/2011CA2475764C New inhibitors of histone deacetylase
05/26/2011WO2011061277A1 Amino aryl acetamides and their use in the treatment of malaria
05/26/2011WO2011024079A3 Peptoid agonists of nerve growth factor and their use as medicaments
05/26/2011WO2011000566A3 Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
05/26/2011US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter
05/26/2011US20110124648 Glucagon receptor antagonists, preparation and therapeutic uses
05/26/2011US20110123873 Quaternary ammonium salt and composition, and electrochemical device
05/25/2011EP2323998A1 Aryl-sulphonamidic dimers as metalloproteases inhibitors
05/25/2011EP1680395B1 Novel ligand activating rar receptors used in human medicine and cosmetics
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102070459A Method for preparing amino-compound through catalytic reduction of nitro-compound
05/25/2011CN101544616B Novel method for synthesizing dyclonine hydrochloride
05/25/2011CN101309913B Process for the preparation of delmopinol and derivatives thereof
05/24/2011US7947854 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
05/24/2011US7947838 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
05/24/2011US7947828 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
05/24/2011US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
05/24/2011US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands
05/24/2011US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/24/2011US7947684 anticoagulants; immunomoderators; antiinflammatory agents
05/24/2011US7947513 Sets and compositions pertaining to analyte determination
05/24/2011CA2453901C Substituted 4-aminocyclohexanols
05/24/2011CA2441235C Aryl and biaryl compounds having mch modulatory activity
05/19/2011WO2011059042A1 Aromatic ring compound
05/19/2011WO2011058932A1 N-benzyl amide derivative and pharmaceutical composition containing same
05/19/2011US20110118307 Compositions and methods for the treatment of infectious diseases
05/19/2011US20110117591 Chemical probe compounds that become fluorescent upon reduction, and methods for their use
05/19/2011US20110117214 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
05/19/2011US20110117125 Compositions and methods for the delivery of nucleic acids
05/19/2011US20110117055 Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
05/19/2011CA2780940A1 Crystalline forms of neurotrophin mimetic compounds and their salts
05/18/2011EP2322501A1 4-dedimethylamino tetracycline compounds
05/18/2011EP2321011A1 Diaryl compounds and uses thereof
05/18/2011EP2320954A1 Diagnostic agents selective against metalloproteases
05/18/2011EP1698618B1 Benzamide derivative
05/18/2011EP1318140B1 Novel amide derivatives and medicinal use thereof
05/18/2011EP1295871B1 Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
05/18/2011CN102066259A Synthesis and use of MSE-framework type molecular sieves
05/18/2011CN102060811A Synthetic method of monosulfonyl piperazine
05/18/2011CN102060810A Method for purifying N-butylcarbonyl-piperazine
05/18/2011CN102060809A Rhein derivatives and preparation and application thereof
05/18/2011CN102060808A Cinepazide acid addition salt and preparation method thereof
05/18/2011CN102060807A Improved preparation process of pinaverium bromide
05/18/2011CN102060806A Cytokine inhibitors
05/18/2011CN102060712A Method for preparing 4-trifluoromethylphenyl piperazine
05/18/2011CN102060684A Para-position or meta-position functional group aromatic ketone compounds, preparation method and photopolymerization initiator thereof
05/18/2011CN101492431B Method for preparing cinepazide maleate
05/18/2011CN101282933B Novel NK1 and NK2 antagonists
05/17/2011US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases
05/17/2011US7943621 Salts of piperazine compounds as D3/D2 antagonists
05/17/2011US7943620 Anti-anginal compounds
05/17/2011US7943613 Compounds, their preparation and use
05/17/2011US7943612 Compounds that modulate PPAR activity, their preparation and use
05/17/2011CA2411409C Vitamin d derivatives
05/12/2011WO2011056448A1 Vinyl ether compounds and methods of their preparation and use
05/12/2011WO2011055142A2 1,4-quinones and their sulfur analogues useful as ligands of n-acetyltransferases
05/12/2011WO2011054185A1 Optical isomers of aralkyl piperazine derivative, preparation methods and uses thereof
05/12/2011WO2011054183A1 Preparation method of optical isomers of 1-butyl-2-hydroxy-aralkyl alcohol piperazine derivative
05/12/2011US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors
05/12/2011US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
05/12/2011US20110111068 Inhibitors of cognitive decline
05/12/2011CA2780149A1 Ire-1.alpha. inhibitors
05/11/2011EP2318383A1 Process for preparing cycloalkyl-substituted piperazine compounds
05/11/2011EP2139877B1 Deuterated piperazine derivatives as anti-anginal compounds
05/11/2011EP1320520B1 Sulfonylguanidine
05/11/2011CN1665801B Anti tubercular drug: compositions and methods
05/11/2011CN102056894A Homocysteine synthase inhibitor
05/11/2011CN102056892A Multifunctional type II photoinitiators and curable compositions
05/11/2011CN102056890A Polymerizable type II photoinitiators and curable compositions
05/11/2011CN102050802A N-(2-ethoxyl)ferulamide nitrate derivative with anoxia resisting pharmaceutical activity and preparation method thereof
05/11/2011CN102050801A Method for preparing arylpiperazines derivative optical isomer
05/11/2011CN102050800A Method for preparing optical isomers of 1-butyl-2-hydroxyarylalkanol piperazine derivative
05/11/2011CN102050758A Novel amide derivatives and medicinal use thereof
05/11/2011CN101665473B Substituted benzene propenyl piperazinyl alkyl polyhydric benzamide compound and preparation method and application thereof
05/11/2011CN101508685B Improved preparation method for cinepazide maleate
05/10/2011US7939666 Enzyme inhibitors
05/10/2011US7939659 Biological buffers with wide buffering ranges
05/10/2011US7939537 HIV integrase inhibitors
05/10/2011US7939525 Conjugated psychotropic drugs and uses thereof
05/10/2011CA2478335C Amino-methyl substituted tetracycline compounds
05/05/2011WO2011052388A1 Iodobenzene derivative and process for preparation of optically active spirolactone compound using same
05/05/2011WO2011051692A1 Therapeutic peptides
05/05/2011WO2011051375A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
05/05/2011WO2011051282A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
05/05/2011WO2010029436A3 Novel solid state forms of ranolazine salts
05/05/2011WO2005060456A9 Method for treating adamts-5-associate disease
05/05/2011US20110105571 Opioid Receptor Antagonists
05/05/2011US20110105507 Vinyl ether compounds and methods of their preparation and use
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 341